Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Regla Nava, Jose Angel ^a   Elong Ngono, Annie ^a   Viramontes, Karla M ^a   Huynh, Anh Thy ^a   Wang, Ying Ting ^a   Nguyen, Anh Viet T ^a   Salgado, Rebecca ^a   Mamidi, Anila ^a   Kim, Kenneth ^a   Diamond, Michael S ^b   Shresta, Sujan ^a,c  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CROSS REACTING ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN; VIRUS RNA; EPITOPE;

CELL; CELL COMPONENT; DENGUE FEVER; ENDEMIC SPECIES; IMMUNE SYSTEM; IMMUNITY; IMMUNIZATION; INFECTIOUS DISEASE; PEPTIDE; PREGNANCY; RNA; VACCINE; ZIKA VIRUS DISEASE;

ADOPTIVE TRANSFER; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL OUTCOME; CONTROLLED STUDY; CROSS PROTECTION; CYTOTOXICITY; DECIDUA; DENGUE VIRUS; DEPLETION; FEMALE; FETUS; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PLACENTAL TRANSFER; PREGNANCY; SPLEEN; VERTICAL TRANSMISSION; ZIKA FEVER; ANIMAL; C57BL MOUSE; CROSS REACTION; IMMUNOLOGY; PATHOLOGY; SPECIES DIFFERENCE; VIROLOGY; VIRUS LOAD; ZIKA VIRUS;

DENGUE VIRUS; MUS; ZIKA VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; DECIDUA; DENGUE VIRUS; EPITOPES; FEMALE; FETUS; MICE, INBRED C57BL; PHENOTYPE; PREGNANCY; SPECIES SPECIFICITY; SPLEEN; VIRAL LOAD; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85051060836     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05458-0     Document Type: Article

References (74)

1. Cao-Lormeau, V. M. et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531–1539 (2016)
2. Driggers, R. W. et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N. Engl. J. Med. 374, 2142–2151 (2016)
3. Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, L. R. Zika virus and birth defects--reviewing the evidence for causality. N. Engl. J. Med. 374, 1981–1987 (2016)
4. Munoz-Suano, A., Kallikourdis, M., Sarris, M. & Betz, A. G. Regulatory T cells protect from autoimmune arthritis during pregnancy. J. Autoimmun. 38, J103–J108 (2012)
5. Constantin, C. M. et al. Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy. J. Immunol. 179, 4383–4389 (2007)
6. Erlebacher, A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat. Rev. Immunol. 13, 23–33 (2013)
7. Arora, N., Sadovsky, Y., Dermody, T. S. & Coyne, C. B. Microbial vertical transmission during human pregnancy. Cell Host Microbe 21, 561–567 (2017)
8. King, N. J. C., Teixeira, M. M. & Mahalingam, S. Zika virus: mechanisms of infection during pregnancy. Trends Microbiol. 25, 701–702 (2017)
9. Anders, A. P., Gaddy, J. A., Doster, R. S. & Aronoff, D. M. Current concepts in maternal-fetal immunology: recognition and response to microbial pathogens by decidual stromal cells. Am. J. Reprod. Immunol. 77 (2017). 10.1111/aji.12623
10. Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081–1091 (2016)
11. Yockey, L. J. et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247–1256 e1244 (2016)
12. Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271 (2016)
13. Quicke, K. M. et al. Zika Virus infects human placental macrophages. Cell Host Microbe 20, 83–90 (2016)
14. Jurado, K. A. et al. Zika virus productively infects primary human placenta-specific macrophages. JCI Insight 1, e88461 (2016)
15. Vermillion, M. S. et al. Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat. Commun. 8, 14575 (2017)
16. Mysorekar, I. U. & Diamond, M. S. Modeling Zika virus infection in pregnancy. N. Engl. J. Med. 375, 481–484 (2016)
17. Li, C. et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19, 120–126 (2016)
18. Wu, K. Y. et al. Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res. 26, 645–654 (2016)
19. Ngono, A. E. & Shresta, S. Immune response to Dengue and Zika. Annu. Rev. Immunol. 36, 279–308 (2018)
20. Halstead, S. B. Pathogenesis of dengue: challenges to molecular biology. Science 239, 476–481 (1988)
21. Goncalvez, A. P., Engle, R. E., St Claire, M., Purcell, R. H. & Lai, C. J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc. Natl Acad. Sci. USA 104, 9422–9427 (2007)
22. Balsitis, S. J. et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6, e1000790 (2010)
23. Zellweger, R. M., Prestwood, T. R. & Shresta, S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7, 128–139 (2010)
24. Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929–932 (2017)
25. Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+T cells. Proc. Natl Acad. Sci. USA 110, E2046–E2053 (2013)
26. Weiskopf, D. et al. Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets. J. Infect. Dis. 212, 1743–1751 (2015)
27. de Alwis, R. et al. Immunodominant Dengue virus-specific CD8+T cell responses are associated with a memory PD-1+phenotype. J. Virol. 90, 4771–4779 (2016)
28. Weiskopf, D. et al. Dengue virus infection elicits highly polarized CX3CR1+cytotoxic CD4+T cells associated with protective immunity. Proc. Natl Acad. Sci. USA 112, E4256–E4263 (2015)
29. Simon-Loriere, E. et al. Increased adaptive immune responses and proper feedback regulation protect against clinical dengue. Sci. Transl Med. 9, eaal5088 (2017)
30. Rivino, L. et al. Virus-specific T lymphocytes home to the skin during natural dengue infection. Sci. Transl. Med. 7, 278ra235 (2015)
31. Elong Ngono, A. et al. Protective role of cross-reactive CD8 T cells against dengue virus infection. EBioMedicine 13, 284–293 (2016)
32. Zellweger, R. M. et al. CD8+T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice. J. Virol. 89, 6494–6505 (2015)
33. Yauch, L. E. et al. A protective role for dengue virus-specific CD8+T cells. J. Immunol. 182, 4865–4873 (2009)
34. Yauch, L. E. et al. CD4+T cells are not required for the induction of dengue virus-specific CD8+T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 185, 5405–5416 (2010)
35. Prestwood, T. R. et al. Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice. J. Virol. 86, 12561–12570 (2012)
36. Zellweger, R. M., Eddy, W. E., Tang, W. W., Miller, R. & Shresta, S. CD8+T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J. Immunol. 193, 4117–4124 (2014)
37. Zellweger, R. M. et al. Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog. 9, e1003723 (2013)
38. Dudley, D. M. et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat. Commun. 7, 12204 (2016)
39. Elong Ngono, A. et al. Mapping and role of the CD8+T cell response during primary Zika virus infection in mice. Cell Host Microbe 21, 35–46 (2017)
40. Priyamvada, L. et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl Acad. Sci. USA 113, 7852–7857 (2016)
41. Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823–826 (2016)
42. Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175–180 (2017)
43. Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17, 1102–1108 (2016)
44. Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio 7, e01123–16 (2016)
45. Kawiecki, A. B. & Christofferson, R. C. Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro. J. Infect. Dis. 214, 1357–1360 (2016)
46. Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+T cells. Nat. Microbiol. 2, 17036 (2017)
47. Grifoni, A. et al. Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. J. Virol. JVI.01469–17 (2017)
48. Paquin-Proulx, D. et al. T-cell responses in individuals infected with Zika virus and in those vaccinated against Dengue virus. Pathog. Immun. 2, 274–292 (2017)
49. Wen, J. et al. Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge. Nat. Commun. 8, 1459 (2017)
50. Pantoja, P. et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat. Commun. 8, 15674 (2017)
51. McCracken, M. K. et al. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 13, e1006487 (2017)
52. Huang, H. et al. CD8+ T cell immune response in immunocompetent mice during Zika virus infection. J. Virol. 91, e00900–e00917 (2017)
53. Sheehan, K. C. et al. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26, 804–819 (2006)
54. Pinto, A. K. et al. A temporal role of type I interferon signaling in CD8+T cell maturation during acute West Nile virus infection. PLoS Pathog. 7, e1002407 (2011)
55. Nishiura, H. Duration of short-lived cross-protective immunity against a clinical attack of dengue: a preliminary estimate (WHO Regional Office for South-East Asia) Dengue Bull. 32, 55–66 (2008)
56. Reich, N. G. et al. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J. R. Soc. Interface 10, 20130414 (2013)
57. SABIN, A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30–50 (1952)
58. Anderson, K. B. et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J. Infect. Dis. 209, 360–368 (2014)
59. Snow, G. E., Haaland, B., Ooi, E. E. & Gubler, D. J. Review article: research on dengue during World War II revisited. Am. J. Trop. Med. Hyg. 91, 1203–1217 (2014)
60. Crespo, A. C., van der Zwan, A., Ramalho-Santos, J., Strominger, J. L. & Tilburgs, T. Cytotoxic potential of decidual NK cells and CD8+T cells awakened by infections. J. Reprod. Immunol. 119, 85–90 (2017)
61. Nancy, P. et al. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336, 1317–1321 (2012)
62. Braga, C. et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop. 113, 234–240 (2010)
63. de Araujo, T. V. B. et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study. Lancet Infect. Dis. 18, 328–336 (2018)
64. Johansson, M. A., Mier-y-Teran-Romero, L., Reefhuis, J., Gilboa, S. M. & Hills, S. L. Zika and the risk of microcephaly. N. Engl. J. Med. 375, 1–4 (2016)
65. van Egmond, A., van der Keur, C., Swings, G. M., Scherjon, S. A. & Claas, F. H. The possible role of virus-specific CD8(+) memory T cells in decidual tissue. J. Reprod. Immunol. 113, 1–8 (2016)
66. Lissauer, D., Kilby, M. D. & Moss, P. Maternal effector T cells within decidua: the adaptive immune response to pregnancy? Placenta 60, 140–144 (2017)
67. Tilburgs, T. & Strominger, J. L. CD8+effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am. J. Reprod. Immunol. 69, 395–407 (2013)
68. Nancy, P. & Erlebacher, A. T cell behavior at the maternal-fetal interface. Int. J. Dev. Biol. 58, 189–198 (2014)
69. Powell, R. M. et al. Decidual T cells exhibit a highly differentiated phenotype and demonstrate potential fetal specificity and a strong transcriptional response to IFN. J. Immunol. 199, 3406–3417 (2017)
70. Lei, J. et al. Maternal CD8(+) T-cell depletion alleviates intrauterine inflammation-induced perinatal brain injury. Am. J. Reprod. Immunol. 79, e12798 (2018)
71. Winkler, C. W. et al. Adaptive immune responses to Zika virus are important for controlling virus infection and preventing infection in brain and testes. J. Immunol. 198, 3526–3535 (2017)
72. Jagger, B. W. et al. Gestational stage and IFN-lambda signaling regulate ZIKV infection in utero. Cell Host Microbe 22, 366–376 e363 (2017)
73. Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R. & Harris, E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80, 10208–10217 (2006)
74. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232–1239 (2008)